K. Yamaguchi et al., MUCIN-HYPERSECRETING TUMORS OF THE PANCREAS - ASSESSING THE GRADE OF MALIGNANCY PREOPERATIVELY, The American journal of surgery, 171(4), 1996, pp. 427-431
BACKGROUND: Mucin-hypersecreting tumor of the pancreas (MHST) is a uni
que variant of pancreatic tumor, where mucin was excreted from the pat
ulous orifice of the enlarged ampulla of Vater and the main pancreatic
duct was dilated with excessive mucin, It is difficult to differentia
te preoperatively between benign and malignant variants. PATIENTS AND
METHODS: A total of 18 patients with an MHST were retrospectively revi
ewed to identify possible indicators of malignancy, The 18 tumors cons
isted of 9 benign lesions (hyperplasia or adenoma with mild to moderat
e atypia), 2 borderline disorders (adenoma with severe atypia), and 7
malignant diseases (unequivocal adenocarcinoma). RESULTS: The age, sex
, and site of origin demonstrated no significant difference among the
three groups, One of the 9 patients with the benign lesion was diabeti
c, while 4 of the 7 patients with the malignant variant were diabetic
(P <0.05), All 9 benign lesions were confined to the side branch, whil
e 4 of the 7 malignant diseases were located in the main pancreatic du
ct (P <0.05), The mean greatest diameters of these three variants were
3.2 cm, 3.3 cm, and 6.6 cm, respectively, The mean greatest diameter
of the main pancreatic duct in the 7 malignant disorders were larger t
han in the 9 benign conditions (9.7 versus 5.4 mm, P <0.05), The mean
diameter of the mural nodules in the 7 malignant tumors were larger th
an in the 9 benign lesions (20.5 versus 5.1 mm, P <0.05), The serum an
d mucin carcinoembryonic antigen and carbohydrate antigen 19-9 levels
showed no substantial difference between the benign and malignant vari
ants.CONCLUSIONS: The presence of diabetes, large tumors (25 cm), mark
ed dilatation of the main pancreatic duct (greater than or equal to 10
mm), main pancreatic duct type, and large mural nodules (greater than
or equal to 10 mm) is strongly suggestive of a malignant variant of t
he MHST.